According to a Dutch study, the overall 10-year contralateral breast cancer risk for unselected BRCA1 or BRCA2 mutation carriers is approximately 18%, whereas that for mutation carriers with a family history of breast cancer is higher, at 25% [18]. This evidence concerns the gene BRCA1 and breast carcinoma.